Acadia Pharmaceuticals (ACAD) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Acadia Pharmaceuticals · Health Care · ref. ETF XLV · 85 calls · price $29.73
What the company does: ACADIA Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics.
📈 Acadia Pharmaceuticals (ACAD) stock price
$29.73+13.3% over range
Aug 28, 25low $20.06 · high $30.57Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
77% recommend buying · 13 analysts
📊 JPI status : Acadia Pharmaceuticals has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 ACAD price target & analyst consensus — price $29.73
The price target · all analysts combined (13 targets)
Highest target · 1 firm of 13$49+64.8%
Median target · of 13 targets$36+21.1%
Lowest target · 2 firms of 13$25-15.9%
Current price$29.73
Where these 13 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1077%
$30 ↔ $49
Below
323%
$25 ↔ $28
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: UBS — 58% of its targets hit on this sector (74 calls tested). It aims for $49 (+65 %), call made on August 18, 2026, maturing on August 18, 2027 (10 d ago).
The 1 reliable analyst
$49+65 %
The 12 other firms
$36+21 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $49 median. “The 12 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 13 ratings (last 6 months)
Strong Buy00%
Buy1077%
Hold323%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 ACAD price target all
All 15 calls, one by one, with our verdict on each firm.
→ See all 15 targets, analyst by analyst💡 The best analysts on ACAD most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in ACAD? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Acadia Pharmaceuticals? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on ACAD
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Cowen & Co. | 100% | +116.5% | 3 |
| McNicoll Lewis Vlak | 100% | +110.2% | 2 |
| B of A Securities ↗ | 100% | +72.5% | 3 |
| Piper Sandler ↗ | 100% | +57.4% | 3 |
| BMO Capital ↗ | 67% | +27.4% | 3 |
| Guggenheim ↗ | 67% | +24.2% | 3 |
| UBS ↗ | 67% | +16.3% | 6 |
| Citigroup ↗ | 57% | +11.8% | 7 |
| Needham ↗ | 56% | +30.0% | 16 |
| RBC Capital ↗ | 50% | +7.6% | 18 |
See the other 14 firms
| Goldman Sachs ↗ | 0% | -40.6% | 3 |
| Mizuho ↗ | 0% | -39.0% | 4 |
| Leerink Swann | 0% | -24.0% | 2 |
| Deutsche Bank ↗ | 0% | -8.5% | 2 |
| Canaccord Genuity ↗ | 14% | -17.9% | 7 |
| JP Morgan ↗ | 20% | -6.0% | 10 |
| Morgan Stanley ↗ | 25% | -24.8% | 12 |
| Baird ↗ | 25% | -9.1% | 4 |
| JMP Securities | 27% | -12.2% | 15 |
| SVB Leerink | 40% | +9.0% | 5 |
| Jefferies ↗ | 40% | +48.6% | 5 |
| Cantor Fitzgerald ↗ | 42% | +5.5% | 24 |
| HC Wainwright & Co. ↗ | 47% | +3.0% | 19 |
| Raymond James ↗ | 50% | -3.6% | 4 |
📊 What $1,000 invested in Acadia Pharmaceuticals would be worth › open the full page
In short — $1,000 invested in Acadia Pharmaceuticals 10 years ago would be worth $715 today, i.e. -3%/yr on average. Best year: 2019 (+165%), worst: 2021 (-56%). Price performance, excluding dividends.
If I'd invested $1,000 in Acadia Pharmaceuticals
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,389 | +39% |
| 3 years ago | $1,601 | +60% |
| 5 years ago | $477 | -52% |
Return by year (Acadia Pharmaceuticals)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -5% | $954 (-5%) |
| 2025 | +46% | $1,389 (+39%) |
| 2024 | -41% | $814 (-19%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Acadia Pharmaceuticals
Loading news…
📋 All analyst calls on ACAD
Filtered on — · ✕ show all
Deutsche Bank ↗
Aug 25, 26
▲ Buy · 🎯$38
Price at call : $29.58 — upside +28%
Today : $29.73 — upside +28%
🎯 on ACAD : no call matured yet · 📊 on Health : 32.7% · -7.6% (55 calls)
in progress (365j)
matures : Aug 25, 27
matures : Aug 25, 27
Morgan Stanley ↗
Aug 25, 26
■ Equal-Weight neutral · not a buy · 🎯$28
Price at call : $29.58 — gap to target -5%
Today : $29.73 — gap to target -6%
🎯 on ACAD : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Aug 25, 27
matures : Aug 25, 27
▲ Buy · 🎯$40
Price at call : $29.58 — upside +35%
Today : $29.73 — upside +35%
🎯 on ACAD : no call matured yet · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Aug 25, 27
matures : Aug 25, 27
▲ Buy · 🎯$49
Price at call : $30.18 — upside +62%
Today : $29.73 — upside +65%
🎯 on ACAD : 100% (1 call matured) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Aug 17, 27
matures : Aug 17, 27
▲ Buy · 🎯$41
Price at call : $29.45 — upside +39%
Today : $29.73 — upside +38%
🎯 on ACAD : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Aug 12, 27
matures : Aug 12, 27
▲ Buy · 🎯$39
Price at call : $29.41 — upside +33%
Today : $29.73 — upside +31%
🎯 on ACAD : no call matured yet · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
Oppenheimer ↗
Aug 5, 26
■ Perform neutral · not a buy · 🎯$25
Price at call : $28.45 — gap to target -12%
Today : $29.73 — gap to target -16%
🎯 on ACAD : no call matured yet · 📊 on Health : 47.3% · +6.3% (93 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
RBC Capital ↗
Aug 5, 26
▲ Outperform · 🎯$37
Price at call : $28.45 — upside +30%
Today : $29.73 — upside +24%
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
See the other 77 calls, newest to oldest
Citizens
Aug 5, 26
▲ Market Outperform · 🎯$36
Price at call : $28.45 — upside +27%
Today : $29.73 — upside +21%
🎯 on ACAD : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
BMO Capital ↗
Jul 21, 26
▲ Outperform · 🎯$36
Price at call : $25.43 — upside +42%
Today : $29.73 — upside +21%
🎯 on ACAD : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Jul 21, 27
matures : Jul 21, 27
■ Hold neutral · not a buy · 🎯$25
Price at call : $25.43 — gap to target -2%
Today : $29.73 — gap to target -16%
🎯 on ACAD : no call matured yet · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Jul 21, 27
matures : Jul 21, 27
RBC Capital ↗
Jul 7, 26
▲ Outperform · 🎯$36
Price at call : $26 — upside +38%
Today : $29.73 — upside +21%
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
B of A Securities ↗
Jun 30, 26
▲ Buy · 🎯$30
Price at call : $25.2 — upside +19%
Today : $29.73 — upside +1%
🎯 on ACAD : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Jun 30, 27
matures : Jun 30, 27
▲ Buy · 🎯$35
Price at call : $25.3 — upside +38%
Today : $29.73 — upside +18%
🎯 on ACAD : no call matured yet · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Jun 29, 27
matures : Jun 29, 27
Canaccord Genuity ↗
Jun 29, 26
▲ Buy · 🎯$36
Price at call : $25.3 — upside +42%
Today : $29.73 — upside +21%
🎯 on ACAD : no call matured yet · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Jun 29, 27
matures : Jun 29, 27
▲ Buy · 🎯$32
Price at call : $21.8 — upside +47%
Today : $29.73 — upside +8%
🎯 on ACAD : no call matured yet · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
Canaccord Genuity ↗
May 7, 26
▲ Buy · 🎯$32
Price at call : $22.4 — upside +43%
Today : $29.73 — upside +8%
🎯 on ACAD : no call matured yet · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
B of A Securities ↗
Mar 25, 26
▲ Buy · 🎯$29
Price at call : $22.01 — upside +32%
Today : $29.73 — upside -2%
🎯 on ACAD : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Mar 25, 27
matures : Mar 25, 27
▲ Overweight · 🎯$34
Price at call : $22.4 — upside +52%
Today : $29.73 — upside +14%
🎯 on ACAD : 100% (1 call matured) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Mar 4, 27
matures : Mar 4, 27
Canaccord Genuity ↗
Feb 27, 26
▲ Buy · 🎯$33
Price at call : $22.81 — upside +45%
Today : $29.73 — upside +11%
🎯 on ACAD : no call matured yet · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
▲ Buy · 🎯$37
Price at call : $24.56 — upside +51%
Today : $29.73 — upside +24%
🎯 on ACAD : no call matured yet · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
RBC Capital ↗
Feb 26, 26
▲ Outperform · 🎯$30
Price at call : $24.56 — upside +22%
Today : $29.73 — upside +1%
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Citizens
Feb 26, 26
▲ Market Outperform · 🎯$35
Price at call : $24.56 — upside +43%
Today : $29.73 — upside +18%
🎯 on ACAD : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
■ Hold neutral · not a buy · 🎯$24
Price at call : $24.64 — gap to target -3%
Today : $29.73 — gap to target -19%
🎯 on ACAD : no call matured yet · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Wolfe Research ↗
Feb 24, 26
▲ Outperform · 🎯$33
Price at call : $24.59 — upside +34%
Today : $29.73 — upside +11%
🎯 on ACAD : no call matured yet · 📊 overall : 35.2% · -2.7% (105 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
▲ Outperform · 🎯$35
Price at call : $24.73 — upside +42%
Today : $29.73 — upside +18%
🎯 on ACAD : no call matured yet · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Feb 23, 27
matures : Feb 23, 27
Oppenheimer ↗
Feb 6, 26
■ Perform neutral · not a buy · 🎯$23
Price at call : $23.22 — gap to target -1%
Today : $29.73 — gap to target -23%
🎯 on ACAD : no call matured yet · 📊 on Health : 47.3% · +6.3% (93 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
RBC Capital ↗
Feb 3, 26
▲ Outperform · 🎯$31
Price at call : $24.23 — upside +28%
Today : $29.73 — upside +4%
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
Citizens
Feb 3, 26
▲ Market Outperform · 🎯$34
Price at call : $24.76 — upside +37%
Today : $29.73 — upside +14%
🎯 on ACAD : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
HC Wainwright & Co. ↗
Feb 3, 26
▲ Buy · 🎯$37
Price at call : $24.76 — upside +49%
Today : $29.73 — upside +24%
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
▲ Buy · 🎯$36
Price at call : $27.42 — upside +31%
Today : $29.73 — upside +21%
🎯 on ACAD : no call matured yet · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Jan 6, 27
matures : Jan 6, 27
▲ Buy · 🎯$40
Price at call : $27.42 — upside +46%
Today : $29.73 — upside +35%
🎯 on ACAD : 100% (1 call matured) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Jan 6, 27
matures : Jan 6, 27
HC Wainwright & Co. ↗
Dec 15, 25
▲ Buy · 🎯$37
Price at call : $26.8 — upside +38%
Today : $29.73 — upside +24%
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
■ Hold neutral · not a buy · 🎯$25
Price at call : $26.68 — gap to target -6%
Today : $29.73 — gap to target -16%
🎯 on ACAD : no call matured yet · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Dec 11, 26
matures : Dec 11, 26
■ Neutral neutral · not a buy · 🎯$29
Price at call : $25.88 — gap to target +12%
Today : $29.73 — gap to target -2%
🎯 on ACAD : no call matured yet · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
▲ Overweight · 🎯$31
Price at call : $23.8 — upside +30%
Today : $29.73 — upside +4%
🎯 on ACAD : 100% (1 call matured) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Nov 17, 26
matures : Nov 17, 26
RBC Capital ↗
Nov 6, 25
▲ Outperform · 🎯$32
Price at call : $22.57 — upside +42%
Today : $29.73 — upside +8%
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Buy · 🎯$29
Price at call : $21.65 — upside +34%
Today : $29.73 — upside -2%
🎯 on ACAD : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Buy · 🎯$33
Price at call : $21.27 — upside +55%
Today : $29.73 — upside +11%
🎯 on ACAD : no call matured yet · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Oct 21, 26
matures : Oct 21, 26
▲ Overweight · 🎯$33
Price at call : $21.32 — upside +55%
Today : $29.73 — upside +11%
🎯 on ACAD : 100% (1 call matured) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Sep 29, 26
matures : Sep 29, 26
▲ Buy · 🎯$28
Price at call : $21.21 — upside +32%
Today : $29.73 — upside -6%
🎯 on ACAD : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
▲ Buy · 🎯$39
Price at call : $24.2 — upside +61%
Today : $29.73 — upside +31%
🎯 on ACAD : no call matured yet · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : Sep 11, 26
matures : Sep 11, 26
▲ Buy · 🎯$39
Price at call : $23.8 — upside +64%
Today : $29.73 — upside +31%
🎯 on ACAD : 100% (1 call matured) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Sep 9, 26
matures : Sep 9, 26
▲ Buy · 🎯$36
Price at call : $24.82 — upside +45%
Today : $29.73 — upside +21%
Expected +45% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on ACAD : 100% (1 call matured) · 📊 on Health : 50% · +2.7% (74 calls)
+18.4%
stock +18% · XLV +29%
matured Aug 8, 26
B of A Securities ↗
Aug 7, 25
■ Neutral neutral · not a buy · 🎯$27
Price at call : $24.6 — gap to target +10%
Today : $29.73 — gap to target -9%
🎯 on ACAD : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Aug 7, 26
matures : Aug 7, 26
Goldman Sachs ↗
Aug 7, 25
▼ Sell · 🎯$17
Price at call : $24.6 — upside -31%
Today : $29.73 — upside -43%
Expected -31% · Actual +19% · Reason (≤ −15%) : ✗ No
🎯 on ACAD : 0% (1 call matured) · 📊 on Health : 51% · +5.1% (102 calls)
-19.5%
stock +19% · XLV +29%
matured Aug 7, 26
RBC Capital ↗
Aug 7, 25
▲ Outperform · 🎯$40
Price at call : $24.6 — upside +63%
Today : $29.73 — upside +35%
Expected +63% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+19.5%
stock +19% · XLV +29%
matured Aug 7, 26
■ Neutral neutral · not a buy · 🎯$24
Price at call : $24.4 — gap to target -2%
Today : $29.73 — gap to target -19%
🎯 on ACAD : no call matured yet · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Aug 7, 26
matures : Aug 7, 26
JMP Securities
Aug 7, 25
▲ Market Outperform · 🎯$38
Price at call : $24.4 — upside +56%
Today : $29.73 — upside +28%
Expected +56% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on ACAD : 100% (1 call matured) · 📊 unranked overall
+19.7%
stock +20% · XLV +28%
matured Aug 7, 26
▲ Overweight · 🎯$34
Price at call : $23.25 — upside +46%
Today : $29.73 — upside +14%
Expected +46% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 100% (1 call matured) · 📊 on Health : 49.3% · +6.9% (146 calls)
+9.2%
stock +9% · XLV +20%
matured Jul 24, 26
HC Wainwright & Co. ↗
Jun 26, 25
▲ Buy · 🎯$32
Price at call : $22.21 — upside +44%
Today : $29.73 — upside +8%
Expected +44% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+14.0%
stock +14% · XLV +19%
matured Jun 26, 26
RBC Capital ↗
Jun 23, 25
▲ Outperform · 🎯$38
Price at call : $22.41 — upside +70%
Today : $29.73 — upside +28%
Expected +70% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+4.2%
stock +4% · XLV +15%
matured Jun 23, 26
RBC Capital ↗
May 19, 25
▲ Outperform · 🎯$26
Price at call : $21.69 — upside +20%
Today : $29.73 — upside -13%
Expected +20% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-3.4%
stock -3% · XLV +9%
matured May 19, 26
HC Wainwright & Co. ↗
May 19, 25
▲ Buy · 🎯$32
Price at call : $21.99 — upside +46%
Today : $29.73 — upside +8%
Expected +46% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
-6.9%
stock -7% · XLV +10%
matured May 19, 26
Cantor Fitzgerald ↗
Feb 27, 25
▲ Overweight · 🎯$28
Price at call : $19.6 — upside +43%
Today : $29.73 — upside -6%
Expected +43% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ACAD : 25% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+16.4%
stock +16% · XLV +6%
matured Feb 27, 26
HC Wainwright & Co. ↗
Feb 27, 25
▲ Buy · 🎯$27
Price at call : $19.34 — upside +40%
Today : $29.73 — upside -9%
Expected +40% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+27.0%
stock +27% · XLV +9%
matured Feb 27, 26
HC Wainwright & Co. ↗
Nov 7, 24
▲ Buy · 🎯$27
Price at call : $17.2 — upside +57%
Today : $29.73 — upside -9%
Expected +57% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+31.2%
stock +31% · XLV -2%
matured Nov 7, 25
HC Wainwright & Co. ↗
Aug 8, 24
▲ Buy · 🎯$27
Price at call : $15.72 — upside +72%
Today : $29.73 — upside -9%
Expected +72% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+56.5%
stock +56% · XLV -13%
matured Aug 8, 25
Cantor Fitzgerald ↗
Aug 7, 24
▲ Overweight · 🎯$28
Price at call : $15.72 — upside +78%
Today : $29.73 — upside -6%
Expected +78% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on ACAD : 25% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+56.5%
stock +56% · XLV -13%
matured Aug 7, 25
RBC Capital ↗
Aug 7, 24
▲ Outperform · 🎯$26
Price at call : $15.72 — upside +65%
Today : $29.73 — upside -13%
Expected +65% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+56.5%
stock +56% · XLV -13%
matured Aug 7, 25
RBC Capital ↗
Jun 25, 24
▲ Outperform · 🎯$29
Price at call : $15.5 — upside +87%
Today : $29.73 — upside -2%
Expected +87% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+43.3%
stock +43% · XLV -8%
matured Jun 25, 25
HC Wainwright & Co. ↗
May 9, 24
▲ Buy · 🎯$27
Price at call : $15.25 — upside +77%
Today : $29.73 — upside -9%
Expected +77% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+14.9%
stock +15% · XLV -5%
matured May 9, 25
Cantor Fitzgerald ↗
May 9, 24
▲ Overweight · 🎯$37
Price at call : $15.25 — upside +143%
Today : $29.73 — upside +24%
Expected +143% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 25% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+14.9%
stock +15% · XLV -5%
matured May 9, 25
Cantor Fitzgerald ↗
Apr 30, 24
▲ Overweight · 🎯$37
Price at call : $17.05 — upside +117%
Today : $29.73 — upside +24%
Expected +117% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 25% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-14.5%
stock -15% · XLV -3%
matured Apr 30, 25
Cantor Fitzgerald ↗
Apr 10, 24
▲ Overweight · 🎯$37
Price at call : $17.41 — upside +113%
Today : $29.73 — upside +24%
Expected +113% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 25% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-16.3%
stock -16% · XLV -3%
matured Apr 10, 25
RBC Capital ↗
Mar 12, 24
▲ Outperform · 🎯$30
Price at call : $19.56 — upside +53%
Today : $29.73 — upside +1%
Expected +53% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-14.2%
stock -14% · XLV -2%
matured Mar 12, 25
Cantor Fitzgerald ↗
Mar 12, 24
▲ Overweight · 🎯$37
Price at call : $19.98 — upside +85%
Today : $29.73 — upside +24%
Expected +85% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 25% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-16.1%
stock -16% · XLV -2%
matured Mar 12, 25
HC Wainwright & Co. ↗
Mar 12, 24
▲ Buy · 🎯$33
Price at call : $19.98 — upside +65%
Today : $29.73 — upside +11%
Expected +65% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
-16.1%
stock -16% · XLV -2%
matured Mar 12, 25
HC Wainwright & Co. ↗
Feb 28, 24
▲ Buy · 🎯$33
Price at call : $23.24 — upside +42%
Today : $29.73 — upside +11%
Expected +42% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
-15.7%
stock -16% · XLV +3%
matured Feb 27, 25
Cantor Fitzgerald ↗
Feb 28, 24
▲ Overweight · 🎯$42
Price at call : $23.24 — upside +81%
Today : $29.73 — upside +41%
Expected +81% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 25% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-15.7%
stock -16% · XLV +3%
matured Feb 27, 25
RBC Capital ↗
Feb 28, 24
▲ Outperform · 🎯$35
Price at call : $23.24 — upside +51%
Today : $29.73 — upside +18%
Expected +51% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-15.7%
stock -16% · XLV +3%
matured Feb 27, 25
Cantor Fitzgerald ↗
Feb 2, 24
▲ Overweight · 🎯$42
Price at call : $25.1 — upside +67%
Today : $29.73 — upside +41%
Expected +67% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 25% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-26.3%
stock -26% · XLV +4%
matured Feb 1, 25
Cantor Fitzgerald ↗
Dec 14, 23
▲ Overweight · 🎯$42
Price at call : $28.58 — upside +47%
Today : $29.73 — upside +41%
Expected +47% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 25% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-39.3%
stock -39% · XLV +4%
matured Dec 13, 24
RBC Capital ↗
Nov 3, 23
▲ Outperform · 🎯$33
Price at call : $23.98 — upside +38%
Today : $29.73 — upside +11%
Expected +38% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-39.0%
stock -39% · XLV +14%
matured Nov 2, 24
Cantor Fitzgerald ↗
Aug 22, 23
▲ Overweight · 🎯$42
Price at call : $29.09 — upside +44%
Today : $29.73 — upside +41%
Expected +44% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 25% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-45.2%
stock -45% · XLV +16%
matured Aug 21, 24
HC Wainwright & Co. ↗
Aug 3, 23
▲ Buy · 🎯$33
Price at call : $27.2 — upside +21%
Today : $29.73 — upside +11%
Expected +21% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
-31.0%
stock -31% · XLV +14%
matured Aug 2, 24
Cantor Fitzgerald ↗
Jul 17, 23
▲ Overweight · 🎯$42
Price at call : $32.99 — upside +27%
Today : $29.73 — upside +41%
Expected +27% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 25% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-44.4%
stock -44% · XLV +14%
matured Jul 16, 24
RBC Capital ↗
Jul 14, 23
▲ Outperform · 🎯$33
Price at call : $33.47 — upside -1%
Today : $29.73 — upside +11%
Expected -1% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-46.1%
stock -46% · XLV +13%
matured Jul 13, 24
HC Wainwright & Co. ↗
Jul 14, 23
▲ Buy · 🎯$33
Price at call : $32.18 — upside +3%
Today : $29.73 — upside +11%
Expected +3% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
-44.0%
stock -44% · XLV +12%
matured Jul 13, 24
HC Wainwright & Co. ↗
Jun 14, 23
▲ Buy · 🎯$28
Price at call : $24.14 — upside +16%
Today : $29.73 — upside -6%
Expected +16% · Actual -37% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
-37.5%
stock -37% · XLV +12%
matured Jun 13, 24
Cantor Fitzgerald ↗
May 9, 23
▲ Overweight · 🎯$33
Price at call : $21.65 — upside +52%
Today : $29.73 — upside +11%
Expected +52% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 25% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-29.8%
stock -30% · XLV +8%
matured May 8, 24
RBC Capital ↗
May 9, 23
▲ Outperform · 🎯$27
Price at call : $21.65 — upside +25%
Today : $29.73 — upside -9%
Expected +25% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-29.8%
stock -30% · XLV +8%
matured May 8, 24
HC Wainwright & Co. ↗
May 9, 23
▲ Buy · 🎯$28
Price at call : $21.43 — upside +31%
Today : $29.73 — upside -6%
Expected +31% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
-20.1%
stock -20% · XLV +7%
matured May 8, 24
RBC Capital ↗
Mar 14, 23
▲ Outperform · 🎯$27
Price at call : $20.38 — upside +32%
Today : $29.73 — upside -9%
Expected +32% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-4.0%
stock -4% · XLV +16%
matured Mar 13, 24
RBC Capital ↗
Feb 28, 23
▲ Outperform · 🎯$27
Price at call : $20.69 — upside +30%
Today : $29.73 — upside -9%
Expected +30% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on ACAD : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+14.8%
stock +15% · XLV +15%
matured Feb 28, 24
Frequently asked questions
Should I buy Acadia Pharmaceuticals stock?
This isn't buy advice. For Acadia Pharmaceuticals, the analyst consensus is "Buy", with an average price target of $36.00 (+21% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Acadia Pharmaceuticals). We show the numbers — you decide.
Is it too late to buy Acadia Pharmaceuticals? How high can it go?
The most bullish analyst target on Acadia Pharmaceuticals is $49.00 (+65% above today's price); the average is $36.00. That's the upside they see. Check how reliable those analysts have actually been on Acadia Pharmaceuticals on our site before trusting it.
Is Acadia Pharmaceuticals still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 24 analysts have a real record on Acadia Pharmaceuticals, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Acadia Pharmaceuticals? The case for and against
The arguments for and against, one by one, from the numbers: why invest in ACAD (and why hesitate).
What has Acadia Pharmaceuticals's past performance been?
Historical returns and a "how much if I had invested" calculator: ACAD performance & returns.
What is the best month to buy ACAD?
The 12 months ranked by the stock's past returns: best & worst month to buy ACAD.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX